NEW YORK (GenomeWeb News) – A National Cancer Institute review panel has recommended that the Wistar Institute Cancer Center receive $14.9 million in renewal funding to support resources and infrastructure for a range of molecular cancer research activities.
The five-year renewal will fund Wistar's shared resources, which include molecular screening and imaging tools and genomics research technologies, Philadelphia-based Wistar said last week.
Wistar's shared resources cores, which are available to all of the institute's investigators and affiliates, include facilities for genomics; bioinformatics; proteomics; imaging; molecular screening; protein expression; flow cytometry; histotechnology; translational research; and an animal facility.
Wistar's faculty is divided into three broad and overlapping research areas, including gene expression and regulation, molecular and cellular oncogenesis, and tumor microenvironment and metastasis.
The institute said that in the years leading up to the renewal it has "made a concerted effort to enhance scientific collaboration between programs, which has resulted in an ever increasing number of shared authorship among researchers on public scientific studies, a hallmark of such collaboration."
"We are a small institution, and our shared resources act as force multipliers, augmenting the scientific capabilities of each independent laboratory," Dario Altieri, the institute's director, executive vice president, and chief scientific officer, said in a statement.